A California union that provided major funding for successful ballot campaigns to expand Medicaid in 3 red states this year, is looking ahead to 2020; smoke from the wildfire in Northern California has created dangerous air quality that exceeds pollution levels in China and India; the World Health Organization evacuated 16 people working to contain the Ebola outbreak in the Democratic Republic of the Congo following a rebel attack.
An advocacy project funded by SEIU-United Healthcare Workers West, the California union that provided major funding for successful ballot campaigns to expand Medicaid in 3 red states this year, is looking ahead to 2020, Politico reported. Six remaining states where Medicaid could be expanded through the ballot are Florida, Mississippi, Missouri, Oklahoma, South Dakota, and Wyoming. But lawmakers from remaining holdout states said any campaign sponsored by a California union would face skepticism.
Smoke from the wildfire in Northern California has created dangerous air quality that exceeds pollution levels in China and India, The New York Times reported. For anyone who must go outside, the state public health department recommends P100 masks and N95 respirators, both of which are approved by the National Institute for Occupational Safety and Health for use by firefighters. Health problems, including asthma, allergies, and other issues, will almost surely rise, researchers warned, as large wildfires become more common due to the effects of climate change.
The World Health Organization evacuated 16 people working to contain the Ebola outbreak in the Democratic Republic of the Congo following a rebel attack near where they were staying. The Ebola outbreak response, which is made up of more than 200 people, has been struggling because of the violence in the region, STAT reported. As of Saturday there have been 358 confirmed and probable cases in this outbreak, and 213 of those people have died. It is the third largest Ebola outbreak on record and the largest in Congo’s long history with Ebola outbreaks.
Eculizumab Biosimilar ABP 959 Demonstrates Similarity to Reference in Patients With PNH
December 6th 2023ABP 959, an eculizumab biosimilar in development, has demonstrated similar efficacy and pharmacokinetics to the reference product for patients with paroxysmal nocturnal hemoglobinuria (PNH), according to research at the 2023 American Society of Hematology Annual Meeting.
Read More
Humana Report Shows Benefits of Value-Based Care for Patients, Physicians
December 6th 2023Patients seen at value-based care clinics received more preventive screenings and had lower risks of hospitalization and emergency room visits, according to Humana’s 10th annual value-based care report.
Read More
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More